Central Trust Company’s Denali Therapeutics DNLI Stock Holding History

Central Trust Company’s Portfolio DNLI Stock Details DNLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-4	Closed	–	–	1329
2022 Q2	$0	Hold	4	–	–	﹤0.01%	1383
2022 Q1	$0	Buy	+4	New	+$138	﹤0.01%	1377

Other funds holding DNLI

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Central Trust Company's DNLI Position: Q3 2022 in Review

Central Trust Company sold out of Denali Therapeutics (DNLI) in Q3 2022, closing a stake of 4 shares.

Central Trust Company first reported a position in DNLI in Q1 2022 and held it in 2 quarters. The position peaked at $0 in Q2 2022. 200 funds tracked by Wall St. Rank hold DNLI as of Q3 2022.

Central Trust Company reported no remaining Denali Therapeutics position as of Q3 2022 after selling out during the quarter.
Central Trust Company sold 4 Denali Therapeutics shares in Q3 2022.
Central Trust Company first reported a position in Denali Therapeutics in Q1 2022 and held it in 2 quarters.
Central Trust Company's Denali Therapeutics position peaked at $0 in Q2 2022.
200 funds tracked by Wall St. Rank held Denali Therapeutics as of Q3 2022.

Based on Central Trust Company's 13F filing for Q3 2022, filed 3 Nov 2022.